I am deeply troubled by Mylan's misclassification of the EpiPen as a generic drug. — Amy Klobuchar Copy Share Image
We should look for ways to expedite generic drug approvals, particularly for products that have a long history of being safe and… — Amy Klobuchar Copy Share Image
The higher cost of getting a generic drug approved by regulators means that many old medicines don't face competitors. It's only after… — Scott Gottlieb Copy Share Image
The value that the generic drug industry brings to the U.S. healthcare system is indisputable. — Heather Bresch Copy Share Image
The key to the generic-drug economic model is to keep entry prices low enough to attract multiple competitors. — Scott Gottlieb Copy Share Image
